# Kazia Therapeutics Ltd: Form 20-F for the period ended Jun 30, 2022

- Company: [Kazia Therapeutics Ltd](/companies/kzia.md) (CIK 1075880)
- Form: 20-F
- Filed: 2022-10-17
- Accepted by EDGAR: Oct 17, 2022, 07:09 ET
- Period: 2022-06-30
- Accession: 0001193125-22-263335
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1075880/000119312522263335/d251611d20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1075880/000119312522263335/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2022-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2021-07-01 to 2022-06-30 | AUD 0 | ifrs-full:RevenueFromContractsWithCustomers |
| Income tax | 12 months, 2021-07-01 to 2022-06-30 | −AUD 368.0k | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months, 2021-07-01 to 2022-06-30 | −AUD 24.6m | ifrs-full:ProfitLossAttributableToOwnersOfParent |
| Diluted EPS | 12 months, 2021-07-01 to 2022-06-30 | −AUD 0.19 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months, 2021-07-01 to 2022-06-30 | −AUD 0.19 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months, 2021-07-01 to 2022-06-30 | −AUD 22.8m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Cash and equivalents | at 2022-06-30 | AUD 7.4m | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2022-06-30 | AUD 7.6m | ifrs-full:CurrentAssets |
| Total assets | at 2022-06-30 | AUD 35.0m | ifrs-full:Assets |
| Current liabilities | at 2022-06-30 | AUD 4.7m | ifrs-full:CurrentLiabilities |
| Total liabilities | at 2022-06-30 | AUD 16.3m | ifrs-full:Liabilities |
| Shareholders' equity | at 2022-06-30 | AUD 18.6m | ifrs-full:EquityAttributableToOwnersOfParent |
| Shares outstanding | at 2022-06-30 | 138,755,376 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1075880/000119312522263335/d251611d20f.htm

Filed Oct 17, 2022.
Source: SEC EDGAR, the filing index for accession 0001193125-22-263335. Last ingested by Listed: Nov 2, 2026, 16:21 ET. No prices; not investment advice.